Cite
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.
MLA
Whittam, Daniel H., et al. “Treatment of MOG-IgG-Associated Disorder with Rituximab: An International Study of 121 Patients.” Multiple Sclerosis and Related Disorders, vol. 44, Sept. 2020, p. 102251. EBSCOhost, https://doi.org/10.1016/j.msard.2020.102251.
APA
Whittam, D. H., Cobo-Calvo, A., Lopez-Chiriboga, A. S., Pardo, S., Gornall, M., Cicconi, S., Brandt, A., Berek, K., Berger, T., Jelcic, I., Gombolay, G., Oliveira, L. M., Callegaro, D., Kaneko, K., Misu, T., Capobianco, M., Gibbons, E., Karthikeayan, V., Brochet, B., … Jacob, A. (2020). Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients. Multiple Sclerosis and Related Disorders, 44, 102251. https://doi.org/10.1016/j.msard.2020.102251
Chicago
Whittam, Daniel H, Alvaro Cobo-Calvo, A Sebastian Lopez-Chiriboga, Santiago Pardo, Matthew Gornall, Silvia Cicconi, Alexander Brandt, et al. 2020. “Treatment of MOG-IgG-Associated Disorder with Rituximab: An International Study of 121 Patients.” Multiple Sclerosis and Related Disorders 44 (September): 102251. doi:10.1016/j.msard.2020.102251.